ACTH revisited - potential implications for patients with renal disease
(2000) In Nephrology Dialysis Transplantation 15(7). p.940-942- Abstract
- Adrenocorticotrophic hormone (ACTH) facilitates the synthesis of adrenal glucocorticoids by maintaining the enzymes that control the side-chain cleavage of cholesterol, the rate-limiting step in the biosynthesis of steroids 1]. Thus, ACTH is involved in the control of adrenal lipid metabolism. Recent studies have revealed that treatment with ACTH in pharmacological dosage also influences plasma lipoprotein metabolism. This applies to both healthy individuals [2–4] and patients with different types of renal disease [5–7]. Moreover, the results of one of these recent studies suggest that treatment with ACTH has beneficial effects on the glomerular function of patients with idiopathic membranous nephropathy [7].
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1267096
- author
- Berg, Anna-Lena LU and Arnadottir, Margret
- organization
- publishing date
- 2000
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nephrology Dialysis Transplantation
- volume
- 15
- issue
- 7
- pages
- 940 - 942
- publisher
- Oxford University Press
- external identifiers
-
- scopus:0034126615
- ISSN
- 1460-2385
- DOI
- 10.1093/ndt/15.7.940
- language
- English
- LU publication?
- yes
- id
- bb05e58a-6346-47e3-8e67-40ba485f6658 (old id 1267096)
- date added to LUP
- 2016-04-01 17:04:46
- date last changed
- 2022-01-29 00:11:59
@article{bb05e58a-6346-47e3-8e67-40ba485f6658, abstract = {{Adrenocorticotrophic hormone (ACTH) facilitates the synthesis of adrenal glucocorticoids by maintaining the enzymes that control the side-chain cleavage of cholesterol, the rate-limiting step in the biosynthesis of steroids 1]. Thus, ACTH is involved in the control of adrenal lipid metabolism. Recent studies have revealed that treatment with ACTH in pharmacological dosage also influences plasma lipoprotein metabolism. This applies to both healthy individuals [2–4] and patients with different types of renal disease [5–7]. Moreover, the results of one of these recent studies suggest that treatment with ACTH has beneficial effects on the glomerular function of patients with idiopathic membranous nephropathy [7].}}, author = {{Berg, Anna-Lena and Arnadottir, Margret}}, issn = {{1460-2385}}, language = {{eng}}, number = {{7}}, pages = {{940--942}}, publisher = {{Oxford University Press}}, series = {{Nephrology Dialysis Transplantation}}, title = {{ACTH revisited - potential implications for patients with renal disease}}, url = {{http://dx.doi.org/10.1093/ndt/15.7.940}}, doi = {{10.1093/ndt/15.7.940}}, volume = {{15}}, year = {{2000}}, }